Cargando…
Chemotherapy and its evolving role in the management of advanced prostate cancer
Advanced prostate cancer has been recognized as being responsive to androgen deprivation since the 1940s when Charles Huggins first described the role of surgical castration in managing these patients. However, androgen deprivation only results in transient disease control for the vast majority of m...
Autores principales: | Schweizer, Michael T, Antonarakis, Emmanuel S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023356/ https://www.ncbi.nlm.nih.gov/pubmed/24435058 http://dx.doi.org/10.4103/1008-682X.122593 |
Ejemplares similares
-
Role of chemotherapy in prostate cancer
por: Nader, Rita, et al.
Publicado: (2018) -
Prostate cancer in East Asia: evolving trend over the last decade
por: Zhu, Yao, et al.
Publicado: (2015) -
Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer
por: Zhang, Jingsong
Publicado: (2014) -
Enzalutamide in chemo-naïve castration-resistant prostate cancer: effective for most but not for all
por: Maughan, Benjamin L, et al.
Publicado: (2014) -
The evolving genomic classification of lung cancer
por: Shames, David S, et al.
Publicado: (2014)